In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘chemotherapy’ clear

  • Dr. David Frank, who says that tracking drug pedigree is paramount in determining its authenticity, explained how Dana-Farber checks the provenance of all drugs its caregivers use.

Tags: chemotherapy, PatientSafety

  • Sylvia Bartel, RPh, says the current drug shortages, especially for drugs that have been around for some years, is likely tied to the economics around generic drugs.

Tags: chemotherapy, PatientSupport

  • Dr. James Butrynski says for the majority of patients being treated with Doxil, changing treatment is a challenge because there's a risk that another medication won't be as successful. Sylvia Bartel, RPh, said that Dana-Farber has dedicated a full-time member of the pharmacy staff to monitor drug supplies, something she says they have never had to worry about until recently.

Tags: chemotherapy, PatientSupport

  • A study by researchers at Dana-Farber shows many patients with advanced cancers put false hope in chemotherapy. The study, published in the New England Journal of Medicine, found 69 percent of patients with lung cancer and 81 percent of those with colorectal cancer did not report understanding chemotherapy was not likely to cure their cancer.

Tags: chemotherapy, BasicResearch, EndOfLife

  • A study led by Dr. Jane Weeks suggests that many patients with advanced lung and colorectal cancer harbor the fundamental misperception that treatments that can extend life and alleviate pain might also cure them. Dr. Deborah Schrag, co-author of the study, said the researchers were also interested in examining whether where doctors worked might affect the way the message was communicated.

Tags: chemotherapy, BasicResearch, EndOfLife

  • In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.

Tags: chemotherapy, EndOfLife

  • Dr. Matthew Kulke writes that the diagnosis and treatment of advanced pancreatic neuroendocrine tumors have recently been boosted by a number of clinical developments. In the past year, two drugs have been approved for these obscure long-neglected tumors. (Subscription needed to view this article)

Tags: chemotherapy, PancreaticCancer

  • Three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers, including those that are rare, such as liposarcoma, a cancer of the fat cells. According to Dr. Andrew J. Wagner, liposarcoma tumors can be very large and often start at the back of a patient's belly, where they can go unnoticed.

Tags: chemotherapy, Genetics

  • In response to a recent New York Times article, Cellceutix Corporation of Beverly said it is already testing a P53 drug called Kevetrin in clinical trials at Dana-Farber.

Tags: chemotherapy

  • Researchers at Dana-Farber/Children’s Hospital Cancer Center, including Dr. Amy Billett, were part of a study in the New England Journal of Medicine that reports that the scarcity of mechlorethamine has been linked to a higher rate of relapse among children and young adults with Hodgkin lymphoma.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

Showing 1-10 of 15 items